171 related articles for article (PubMed ID: 32307006)
1. Functional adrenal insufficiency among tuberculosis-human immunodeficiency virus co-infected patients: a cross-sectional study in Uganda.
Naggirinya AB; Mujugira A; Meya DB; Biraro IA; Mupere E; Worodria W; Manabe YC
BMC Res Notes; 2020 Apr; 13(1):224. PubMed ID: 32307006
[TBL] [Abstract][Full Text] [Related]
2. The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis.
Matulyte E; Davidaviciene E; Kancauskiene Z; Diktanas S; Kausas A; Velyvyte D; Urboniene J; Lipnickiene V; Laurencikaite M; Danila E; Costagliola D; Matulionyte R
PLoS One; 2023; 18(3):e0282046. PubMed ID: 36952578
[TBL] [Abstract][Full Text] [Related]
3. Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting.
Meya DB; Katabira E; Otim M; Ronald A; Colebunders R; Njama D; Mayanja-Kizza H; Whalen CC; Sande M
Afr Health Sci; 2007 Jun; 7(2):101-7. PubMed ID: 17594287
[TBL] [Abstract][Full Text] [Related]
4. Study of adrenal function in patients with tuberculosis.
Sarin BC; Sibia K; Kukreja S
Indian J Tuberc; 2018 Jul; 65(3):241-245. PubMed ID: 29933867
[TBL] [Abstract][Full Text] [Related]
5. Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.
Isaakidis P; Das M; Kumar AM; Peskett C; Khetarpal M; Bamne A; Adsul B; Manglani M; Sachdeva KS; Parmar M; Kanchar A; Rewari BB; Deshpande A; Rodrigues C; Shetty A; Rebello L; Saranchuk P
PLoS One; 2014; 9(10):e110461. PubMed ID: 25333696
[TBL] [Abstract][Full Text] [Related]
6. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.
Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA
Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283
[TBL] [Abstract][Full Text] [Related]
9. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study.
Sinshaw Y; Alemu S; Fekadu A; Gizachew M
BMC Infect Dis; 2017 Feb; 17(1):132. PubMed ID: 28178936
[TBL] [Abstract][Full Text] [Related]
10. Adrenocortical reserve and morphology in tuberculosis.
Prasad GA; Sharma SK; Mohan A; Gupta N; Bajaj S; Saha PK; Misra NK; Kochupillai NP; Pande JN
Indian J Chest Dis Allied Sci; 2000; 42(2):83-93. PubMed ID: 10916272
[TBL] [Abstract][Full Text] [Related]
11. Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis.
Azeez A; Ndege J; Mutambayi R
Int J Mycobacteriol; 2018; 7(4):347-354. PubMed ID: 30531033
[TBL] [Abstract][Full Text] [Related]
12. Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis.
von Braun A; Sekaggya-Wiltshire C; Scherrer AU; Magambo B; Kambugu A; Fehr J; Castelnuovo B
AIDS Res Ther; 2017 Jan; 14(1):1. PubMed ID: 28086929
[TBL] [Abstract][Full Text] [Related]
13. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
[TBL] [Abstract][Full Text] [Related]
14. Ocular inflammatory disease and ocular tuberculosis in a cohort of patients co-infected with HIV and multidrug-resistant tuberculosis in Mumbai, India: a cross-sectional study.
Mehta S; Mansoor H; Khan S; Saranchuk P; Isaakidis P
BMC Infect Dis; 2013 May; 13():225. PubMed ID: 23687908
[TBL] [Abstract][Full Text] [Related]
15. Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection.
Sagwa E; Ruswa N; Musasa JP; Mantel-Teeuwisse AK
Drug Saf; 2013 Nov; 36(11):1087-96. PubMed ID: 23917883
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.
Jones-López EC; Ayakaka I; Levin J; Reilly N; Mumbowa F; Dryden-Peterson S; Nyakoojo G; Fennelly K; Temple B; Nakubulwa S; Joloba ML; Okwera A; Eisenach KD; McNerney R; Elliott AM; Ellner JJ; Smith PG; Mugerwa RD
PLoS Med; 2011 Mar; 8(3):e1000427. PubMed ID: 21423586
[TBL] [Abstract][Full Text] [Related]
17. Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study.
Baluku JB; Mukasa D; Bongomin F; Stadelmann A; Nuwagira E; Haller S; Ntabadde K; Turyahabwe S
BMC Infect Dis; 2021 Oct; 21(1):1093. PubMed ID: 34689736
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
[TBL] [Abstract][Full Text] [Related]
19. Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa.
Fairlie L; Muchiri E; Beylis CN; Meyers T; Moultrie H
Int J Tuberc Lung Dis; 2014 Jun; 18(6):676-81. PubMed ID: 24903938
[TBL] [Abstract][Full Text] [Related]
20. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
Azeez A; Mutambayi R; Odeyemi A; Ndege J
Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
